Ataraxis AI is a high-growth medical technology startup operating at the cutting edge of oncology and artificial intelligence. By leveraging advanced multi-modal AI, the company provides physicians with actionable insights to optimize treatment selection for cancer patients.
As a frontier AI lab, Ataraxis AI brings together top-tier researchers and clinicians to solve some of medicine's most complex challenges. With a significant Series A backing and a bold mission to scale its impact to 50% of new cancer cases globally by 2030, the company offers a unique environment for professionals who want to push the boundaries of technology to save lives.